1. Abd Alla, Mohamed Darwish Ahmed, Dawood, Reham M, Rashed, Hassan Abd El-Hafeth, Abd El-Meguid, Mai, El Awady, Mostafa K. 2023. HCV treatment outcome depends on SNPs of IFNL3-Gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma. In Heliyon, 9, e21194. doi:10.1016/j.heliyon.2023.e21194. https://pubmed.ncbi.nlm.nih.gov/37928048/
2. Zhao, Zhongyi, Qin, Zhen, Zhou, Linlin, Wang, Baoning, Li, Mingyuan. 2019. The impact of IFNL3 genotype on interferon treatment outcome in patients chronically infected with hepatitis B virus: A meta-analysis. In Microbial pathogenesis, 134, 103598. doi:10.1016/j.micpath.2019.103598. https://pubmed.ncbi.nlm.nih.gov/31201901/
3. Amanzada, Ahmad, Reinhardt, Lars, Fey, Dorothea, Zeisberg, Elisabeth M, Mihm, Sabine. 2015. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C. In PloS one, 10, e0143783. doi:10.1371/journal.pone.0143783. https://pubmed.ncbi.nlm.nih.gov/26606750/
4. Singh, Pratichi, Dass, J Febin Prabhu. 2018. Nearly neutral evolution in IFNL3 gene retains the immune function to detect and clear the viral infection in HCV. In Progress in biophysics and molecular biology, 140, 107-116. doi:10.1016/j.pbiomolbio.2018.05.004. https://pubmed.ncbi.nlm.nih.gov/29746888/
智鼠故事 
